A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Chowdhury, Debabrata ^a   Tangutur, Anjana Devi ^a   Khatua, Tarak Nath ^a   Saxena, Priyanka ^b   Banerjee, Sanjay K ^a   Bhadra, Manika Pal ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

2D gels; Cardiac hypertrophy; Differentially expressed proteins; Isoproterenol; Prohibitin; Proteome analysis

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; CHAPERONE; ISOPRENALINE; MYOSIN HEAVY CHAIN BETA; PROHIBITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; CITRIC ACID CYCLE; CONTROLLED STUDY; DISEASE MARKER; DNA SYNTHESIS; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IMMUNOBLOTTING; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE METABOLISM; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEOMICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ANIMALS; BIOLOGICAL MARKERS; CARDIOMEGALY; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART; ISOPROTERENOL; MALE; MYOCYTES, CARDIAC; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84878008442     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-130     Document Type: Article

References (34)

1. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000, 102:470-479. 10.1161/01.CIR.102.4.470, 10908222.
2. Yung CK, Halperin VL, Tomaselli GF, Winslow RL. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 2004, 83:281-297. 10.1016/j.ygeno.2003.08.007, 14706457.
3. Berenji K, Drazner MH, Rothermel BA, Hill JA. Does load-induced ventricular hypertrophy progress to systolic heart failure?. Am J Physiol Heart Circ Physiol 2005, 289:H8-H16. 10.1152/ajpheart.01303.2004, 15961379.
4. Frank D, Kuhn C, Brors B, Hanselmann C, Lüdde M, Katus HA, Frey N. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 2008, 51:309-318. 10.1161/HYPERTENSIONAHA.107.098046, 18158353.
5. Molojavyi A, Lindecke A, Raupach A, Moellendorf S, Köhrer K, Gödecke A. Myoglobin-deficient mice activate a distinct cardiac gene expression program in response to isoproterenol-induced hypertrophy. Physiol Genomics 2010, 41:137-145. 10.1152/physiolgenomics.90297.2008, 20145201.
6. Weihua Z, Vijayan E, Mohinder SN, Suresh KG, Naranjan SD. Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol 2003, 8:173-183. 2719157, 19649217.
7. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovas Res 1998, 39:89-105.
8. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113:2335-2362. 10.1161/CIRCULATIONAHA.104.482570, 16702488.
9. Schleicher M, Shepherd BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 2008, 180:101-112. 10.1083/jcb.200706072, 2213620, 18195103.
10. Osadchii OE. Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects. Heart Fail Review 2007, 12:66-86.
11. Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS One 2008, 3:e2642. 10.1371/journal.pone.0002642, 2441440, 18612386.
12. Laemmli UK. Change of structural protein during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685. 10.1038/227680a0, 5432063.
13. Banerjee SK, Wang DW, Alzamora R, Huang XN, Pastor-Soler NM, Hallows KR, McGaffin KR, Ahmad F. SGLT1, A novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 2010, 49:683-692. 10.1016/j.yjmcc.2010.06.003, 2932762, 20600102.
14. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev 2002, 82:945-980.
15. Wu F, Lee S, Schumacher M, Jun A, Chakravarti S. Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon. Exp Eye Res 2008, 87:214-225. 10.1016/j.exer.2008.06.001, 3043597, 18582462.
16. Casey TM, Arthur PG, Bogoyevitch MA. Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro. Mol Cell Proteom 2005, 4:651-661.
17. Paal SA, Paula LH, Stephen PP, Petros S, Johanna CMS, William JMK, Perry ME, Michael CA. Novel myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivity. Biochem Res Intern 2012, 2012:1-6.
18. Li Y, Wu G, Tang Q, Huang C, Jiang H, Shi L, Tu X, Huang J, Zhu X, Wang H. Slow cardiac myosin regulatory light chain 2 (MYL2) was down-expressed in chronic heart failure patients. Clin Cardiol 2011, 34:30-34. 10.1002/clc.20832, 21259275.
19. Dhiman M, Zago MP, Nunez S, Amoroso A, Rementeria H, Dousset P, Nunez Burgos F, Garg NJ. Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis. PLoS One 2012, 7:e28449. 10.1371/journal.pone.0028449, 3251564, 22238578.
20. Bowles NE, Bowles KR, Towbin JA. The 'final common pathway' hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000, 25:168-175. 10.1007/s000590050003, 10904835.
21. Collins JF, Pawloski-Dabree C, Davis MG, Ball N, Dorn GW, Walsh RA. The role of cytoskeleton in left ventricular pressure overload hypertrophy and failure. J Mol Cell Cardiol 1996, 28:1435-1443.
22. Azzazy HM, Pelsers MM, Christenson RH. Unbound free fatty acids and heart-type fatty acid-binding protein; diagnostic assays and clinical applications. Clin Chem 2006, 52:19-29. 10.1373/clinchem.2005.056143, 16269514.
23. Chen CY, Lee BC, Hsu HC, Lin HJ, Chao CL, Lin YH, Ho YL, Chen MF. A proteomic study of the effects of ramipril on post-infarction left ventricular remodeling in the rabbit. Eu J Heart Fail 2008, 10:740-748.
24. Latchman DS. Heat shock proteins and cardiac protection. Cardiovas Res 2001, 51:637-646.
25. Giannessi D, Colotti C, Maltinti M, Ry SD, Prontera C, Turchi S, L'Abbate A, Neglia D. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 2007, 12:265-274. 10.1379/CSC-272.1, 1971236, 17915559.
26. Dohke T, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M. Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Cardiac Fail 2006, 12:77-84.
27. Schulz TJ, Westermann D, Isken F, Voigt A, Laube B, Thierbach R, Kuhlow D, Zarse K, Schomburg L, Pfeiffer AF, Tschöpe C, Ristow M. Activation of mitochondrial energy metabolism protects against cardiac failure. Aging (Albany NY) 2010, 2:843-853.
28. Artal-Sanz M, Tavernarakis N. Prohibitin and mitochondrial biology. Trends Endocrinol Metab 2009, 20:394-401. 10.1016/j.tem.2009.04.004, 19733482.
29. Artal-Sanz M, Tavernarakis N. Opposing function of mitochondrial prohibitin in aging. Aging 2010, 2:1004-1011. 3034168, 21164222.
30. Ventura-Clapier R, Garnier A, Veksler V, Joubert F. Review: bioenergetics of the failing heart. Biochim Biophys Acta 1813, 2011:1360-1372.
31. Khatua TN, Padiya R, Karnewar S, Kuncha M, Agawane SB, Kotamraju S, Banerjee SK. Garlic provides protection to mice heart against isoproterenol-induced oxidative damage: role of nitric oxide. Nitric Oxide 2012, 27:9-17. 10.1016/j.niox.2012.03.004, 22484451.
32. Theiss AL, Idell RD, Srinivasan S, Klapproth JM, Jones DP, Merlin D, Sitaraman SV. Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J 2001, 21:1-10.
33. Lord KC, Shenouda SK, McIlwain E, Charalampidis D, Lucchesi PA, Varner KJ. Oxidative stress contributes to methamphetamine induced left ventricular dysfunction. Cardiovas Res 2010, 87:111-118.
34. Maulik SK, Prabhakar P, Dinda AK, Seth S. Genistein prevents isoproterenol-induced cardiac hypertrophy in rats. Can J Physiol Pharmacol 2012, 90:1117-1125. 10.1139/y2012-068, 22808991.